Gastroesophageal dysmotility in advanced Parkinson’s Disease
Objective: The aim of this study is to evaluate the patterns of gastroparesis in PD patients with motor fluctuations and dyskinesias. Background: Gastrointestinal dysfunction is…Validation of the performance based Erlangen Test of Activities of Daily Living in PD
Objective: The Erlangen Test of Activities of Daily Living (E-ADL) is a performance-based test to assess the activity of daily living (ADL) dysfunction associated with…The Relationship between Olfactory Function and Clinical Subtypes of Parkinson’s Disease
Objective: The aim of this study was to investigate the relationship between the degree of olfactory function and motor subtype of Parkinson's disease (PD). Background:…Use of pimavanserin in patients with Parkinson’s disease psychosis: Subgroup analysis of efficacy and safety in patients with and without cognitive impairment
Objective: A planned subgroup analysis of a phase 3 study was performed to evaluate the efficacy and safety of pimavanserin (PIM) in Parkinson’s disease psychosis…Parkinson’s disease and progressive dysphagia – consider myasthenia gravis
Objective: We report on three consecutive patients with Parkinson’s disease, in whom myasthenia gravis turned out responsible for progressive dysphagia. Background: Swallowing dysfunction is common…The utility of post-void residual volume versus sphincter electromyography to distinguish between multiple system atrophy and Parkinson’s disease
Objective: To determine the ability of sphincter electromyography (EMG) and post-void residual urine volume (PVR) during a free-flow study and a pressure-flow study (PFS) for…Gait characteristics in Atypical Parkinsonism
Objective: We investigated gait characteristics of progressive supranuclear palsy (PSP) and multiple system atrophy (MSA), with the aim to elucidate relatively specific disease differences in…The environmental and genetic risk factors in multiple system atrophy in a Taiwanese population
Objective: The etiology of MSA remains uncertain. Cholesterol and its metabolism derangements, α-Synuclein and CoQ2 genetic polymorphism have been disclosed to be associated with the…Rolipram, a PDE-IV inhibitor protects against experimental Parkinsonism in mice
Objective: Rolipram, a specific inhibitor of the phosphodiesterase IV (PDE IV), has recently been shown to exert neuroprotective effects in an Alzheimer transgenic mouse model…Gait impairment and cognitive changes in a case of thalamic dementia and motor neuron disease.
Objective: To describe a case of a 54-year-old woman diagnosed with atypical corticobasal syndrome (CBS). Neuropathological studies revealed that she had thalamic dementia with motor…
- « Previous Page
- 1
- …
- 37
- 38
- 39
- 40
- 41
- …
- 155
- Next Page »